$0.86 Earnings Per Share Expected for Nu Skin Enterprises, Inc. (NYSE:NUS) This Quarter

Share on StockTwits

Analysts predict that Nu Skin Enterprises, Inc. (NYSE:NUS) will report $0.86 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Four analysts have made estimates for Nu Skin Enterprises’ earnings. The highest EPS estimate is $0.92 and the lowest is $0.82. Nu Skin Enterprises reported earnings of $1.08 per share in the same quarter last year, which indicates a negative year over year growth rate of 20.4%. The company is scheduled to announce its next quarterly earnings report after the market closes on Tuesday, August 6th.

On average, analysts expect that Nu Skin Enterprises will report full-year earnings of $3.92 per share for the current fiscal year, with EPS estimates ranging from $3.87 to $4.00. For the next fiscal year, analysts expect that the company will post earnings of $4.29 per share, with EPS estimates ranging from $4.20 to $4.53. Zacks’ EPS calculations are an average based on a survey of research analysts that cover Nu Skin Enterprises.

Nu Skin Enterprises (NYSE:NUS) last issued its earnings results on Tuesday, April 30th. The company reported $0.77 EPS for the quarter, topping analysts’ consensus estimates of $0.71 by $0.06. The firm had revenue of $623.60 million during the quarter, compared to the consensus estimate of $615.98 million. Nu Skin Enterprises had a net margin of 4.82% and a return on equity of 26.81%. The company’s revenue was up 1.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.79 earnings per share.

NUS has been the subject of several analyst reports. Bank of America cut their price target on shares of Canopy Growth from $80.00 to $75.00 and set a “buy” rating for the company in a report on Wednesday, June 19th. Deutsche Bank cut shares of Hilton Hotels from a “buy” rating to a “hold” rating and set a $92.60 target price for the company. in a report on Wednesday, May 1st. They noted that the move was a valuation call. Citigroup dropped their target price on shares of Cimarex Energy from $98.00 to $90.00 and set a “buy” rating for the company in a report on Thursday. Stifel Nicolaus set a $99.00 price target on shares of C.H. Robinson Worldwide and gave the company a “hold” rating in a research report on Monday, March 25th. Finally, ValuEngine upgraded shares of Valmont Industries from a “sell” rating to a “hold” rating in a research report on Friday, July 12th. Three investment analysts have rated the stock with a sell rating, three have assigned a hold rating and four have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $55.63.

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. BlackRock Inc. boosted its position in Nu Skin Enterprises by 19.5% during the first quarter. BlackRock Inc. now owns 7,498,023 shares of the company’s stock worth $358,856,000 after acquiring an additional 1,224,725 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in Nu Skin Enterprises by 3.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,132,318 shares of the company’s stock worth $69,442,000 after acquiring an additional 38,282 shares during the last quarter. Norges Bank acquired a new stake in Nu Skin Enterprises during the fourth quarter worth approximately $56,136,000. Acadian Asset Management LLC boosted its position in Nu Skin Enterprises by 29.5% during the first quarter. Acadian Asset Management LLC now owns 615,706 shares of the company’s stock worth $29,466,000 after acquiring an additional 140,367 shares during the last quarter. Finally, Geode Capital Management LLC boosted its position in Nu Skin Enterprises by 7.3% during the fourth quarter. Geode Capital Management LLC now owns 547,265 shares of the company’s stock worth $33,563,000 after acquiring an additional 37,229 shares during the last quarter. Hedge funds and other institutional investors own 77.17% of the company’s stock.

NYSE NUS traded up $0.49 during trading hours on Thursday, hitting $39.34. The company had a trading volume of 1,333,597 shares, compared to its average volume of 702,673. The company has a current ratio of 1.86, a quick ratio of 1.10 and a debt-to-equity ratio of 0.44. Nu Skin Enterprises has a 1-year low of $35.03 and a 1-year high of $88.68. The stock has a market cap of $2.53 billion, a P/E ratio of 11.18, a PEG ratio of 1.04 and a beta of 0.74. The firm has a 50 day moving average of $47.86.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.

Read More: Conference Calls and Individual Investors

Get a free copy of the Zacks research report on Nu Skin Enterprises (NUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.